Clinical Trials Browser

Hodgkin Disease

Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma

Brain Neoplasms, Melanoma, Pancreatic Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Biliary Tract Neoplasms

Neoplasms, Pancreatic Neoplasms

Lymphoma, Extranodal NK-T-Cell

Lung Diseases, Interstitial

Carcinoma, Non-Small-Cell Lung

Liver Neoplasms

Triple Negative Breast Neoplasms

Urinary Bladder Neoplasms

Rhabdoid Tumor

Advanced Squamous Non-Small Cell Lung Cancer

Advanced Biliary Tract Cancer(BTC)

Pancreatic Neoplasms

Non-Muscle Invasive Bladder Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

Urinary Bladder Neoplasms

Nasopharyngeal Carcinoma

CLDN18.2-positive Advanced Biliary Tract Cancer

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

Pancreatic Neoplasms

Biliary Tract Neoplasms

PDAC - Pancreatic Ductal Adenocarcinoma

Biliary Tract Neoplasms

Biliary Tract Neoplasms, Cholangiocarcinoma

Nasopharyngeal Neoplasms, Recurrence

Pancreatic Neoplasms

Thyroid Neoplasms

Pancreatic Neoplasms

Nasopharyngeal Neoplasms

Biliary Tract Neoplasms

Cholangiocarcinoma

Advanced Solid Tumor

Anophthalmia with pulmonary hypoplasia, Pancreatic Neoplasms

Nasopharyngeal Carcinoma

Pancreatic Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Locally Advanced Pancreatic Cancer

Pancreatic Neoplasms

Clinical Trials

ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

REVIVE

GENE

NUMANTIA-2

Selinexor Combined With Reduced-Dose Radiotherapy For Early-Stage Extranodal NK/T-Cell Lymphoma

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

ORIGIN2

A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma

Gemcitabine vs Paclitaxel in Caribbean Women of African Ancestry With Metastatic Triple-Negative Breast Cancer

TRIFECTA

Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)

CECYDE

NOBLE

Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer

Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer

OHAI-NMIBC-01

No Acronym

Perioperative Chemotherapy and Immunotherapy for Locally Recurrent Nasopharyngeal Carcinoma

Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer

EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma

Efficacy and Safety of LM-302 Combined With Gemcitabine CLDN 18.2 Positive Unresectable Locally Advanced or Metastatic Pancreatic Cancer

The Safety and Efficacy of Benmelstobart Injection in Patients With Advanced Biliary Tract Malignant Tumors

PANORAMIX

Envafolimab With Chemotherapy and Simvastatin in Advanced Biliary Tract Cancer

TisGCS for BTC

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer

Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer

SPRING

SASAN-SPARING

Anlotinib Plus Benmelstobart and AG in First-line Treatment of Advanced Metastatic Pancreatic Cancer (ALTER-PA-001)

GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPC

NEOLANGIO

Low-dose Gemcitabine and Cisplatin and PD-1/PD-L1 Antibody Therapy in Intrahepatic Cholangiocarcinoma

Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors

Surufatinib Combined With Gemcitabine Plus Nab-paclitaxel in Locally Advanced Pancreatic Cancer

Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma

Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Patients

POLO

Surufatinib and Serplulimab Combined With AG Regimen Compare With AG Regimen as Conversion Therapy for Patients With Locally Advanced Pancreatic Cancer (SAGE)

AG Combined With Immunotherapy and SBRT in Patients With Potentially Resectable Pancreatic Cancer